Pharmacological issues concerning olaparib capsule and tablet formulations in treating ovarian cancer: Are they really the same drug?

Saved in:
Bibliographic Details
Title: Pharmacological issues concerning olaparib capsule and tablet formulations in treating ovarian cancer: Are they really the same drug?
Authors: Perego G; Pharmacy Unit, Asst Bergamo Ovest, University of Milan, School of Hospital Pharmacy, Milano, Italy., Nozza R; Pharmacy Unit, Asst Bergamo Ovest, University of Milan, School of Hospital Pharmacy, Milano, Italy., Oggionni E; Pharmacy Unit, Asst Bergamo Ovest, University of Milan, School of Hospital Pharmacy, Milano, Italy., Cabiddu M; Oncology Unit, Asst Bergamo Ovest, Treviglio (BG), Italy., Scolari C; Pharmacy Unit, Asst Bergamo Ovest, University of Milan, School of Hospital Pharmacy, Milano, Italy., Omati E; Pharmacy Unit, Asst Bergamo Ovest, University of Milan, School of Hospital Pharmacy, Milano, Italy., Castelli EA; Pharmacy Unit, Asst Bergamo Ovest, University of Milan, School of Hospital Pharmacy, Milano, Italy., Petrelli F; Pharmacy Unit, ASST Bergamo Ovest, Treviglio (BG), Italy.
Source: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners [J Oncol Pharm Pract] 2020 Jun; Vol. 26 (4), pp. 967-971. Date of Electronic Publication: 2020 Feb 10.
Publication Type: Journal Article
Journal Info: Publisher: SAGE Publications Country of Publication: England NLM ID: 9511372 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-092X (Electronic) Linking ISSN: 10781552 NLM ISO Abbreviation: J Oncol Pharm Pract Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1477-092X
DOI:10.1177/1078155219900913